Clinical Trial Update: SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 trial (SR-Registration Study 1) evaluating the efficacy and safety of quetiapine (Seroquel) in patients with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenic Disorder | Phase 3 | Status: COMPLETED